Tags: Allergies | dust mite allergy | HDM SLIT-tablet | pollen allergies | grass allergies

Dust Allergy Help Is On the Way

Thursday, 20 Mar 2014 12:30 PM

 


Danish pharmaceutical group Alk Abello expects to start selling its new dust mite allergy tablet in Europe and Japan around the end 2015 with the U.S. market a further year behind, its Chief Executive told Reuters on Thursday.
The HDM SLIT-tablet, which just entered third phase in the development program in North America, could be the most important of three allergy tablets the company is developing in association with American healthcare company Merck, Alk's Chief Executive Jens Bager said in an interview.
"It is the treatment in which we see both the biggest commercial and economic potential," Bager said.
"House dust mite-allergy is one of the most debilitating allergies and is often associated with allergic asthma and affects more than 30 million Americans."
He said that studies in Europe and Japan show Alk's HDM SLIT-tablet is able to reduce dust mite allergy symptoms significantly, adding that there were few rival medicines on the market.
Alk expects royalties of about 15-20 percent of sales of the three treatments being developed with Merck. The two firms are developing tablets for pollen and grass allergies as well as the dust mite treatment.
 

© 2015 Thomson/Reuters. All rights reserved.

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Bacteria Offer New Way to Treat Cancer: M.D. Anderson Study

Sunday, 01 Feb 2015 11:34 AM

Bacteria may offer a new way to treat cancer, a small, preliminary study suggests.

Researchers injected a wea . . .

Do You Get Winter Nose Bleeds? Here's Help

Sunday, 01 Feb 2015 11:29 AM

Nosebleeds are a common during the winter and shouldn't be cause for concern, an expert says.

Cold winter ai . . .

Drug That Fights Binge Eating OKd by FDA

Saturday, 31 Jan 2015 10:04 AM

The U.S. Food and Drug Administration on Friday approved Shire's stimulant Vyvanse to treat binge-eating disorder, the f . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved